Insilico Medicine and Takeda Launch AI Drug-Discovery Collaboration

Insilico Medicine announced a strategic collaboration with Takeda on July 2, 2026, using Insilico’s Pharma.AI platform to advance drug candidates across Takeda’s therapeutic areas. On this page you can read the full post, open the connected company profile, view related posts, check likes and publication details.
  • Insilico Medicine announced a strategic collaboration with Takeda on July 2, 2026, using Insilico’s Pharma.AI platform to advance drug candidates across Takeda’s therapeutic areas. On this page you can read the full post, open the connected company profile, view related posts, check likes and publication details.